Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             44 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A comparison of anticoagulation results of patients managed with narrow vs. standard international normalized ratio target ranges MEIER, D. J.
2007
5 6 p. 1332-1333
artikel
2 A mechanism to safeguard platelet adhesion under high-shear flow: von Willebrand factor–glycoprotein Ib and integrin α2β1–collagen interactions make complementary, collagen-type-specific contributions to adhesion: a rebuttal LISMAN, T.
2007
5 6 p. 1338-1339
artikel
3 A mechanism to safeguard platelet adhesion under high-shear flow: von Willebrand factor-glycoprotein Ib and integrin α2β1-collagen interactions make complementary, collagen-type-specific contributions to adhesion: reply to a rebuttal MOROI, M.
2007
5 6 p. 1340-1342
artikel
4 ANNOUNCEMENTS 2007
5 6 p. 1344
artikel
5 A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects Zafar, M. U.
2007
5 6 p. 1195-1200
artikel
6 Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study BIZZARO, N.
2007
5 6 p. 1158-1164
artikel
7 Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis WIENEN, W.
2007
5 6 p. 1237-1242
artikel
8 Bilirubin oxidase as a solution for the interference of hyperbilirubinemia with ADAMTS-13 activity measurement by FRETS-VWF73 assay ECKMANN, C. M.
2007
5 6 p. 1330-1331
artikel
9 Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease JAMES, A. H.
2007
5 6 p. 1165-1169
artikel
10 Calibration of the WHO 1st International Standard for blood coagulation factor V in plasma, human (03/116) 1 HUBBARD, A. R.
2007
5 6 p. 1318-1319
artikel
11 Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors WALKER, J. B.
2007
5 6 p. 1257-1264
artikel
12 Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL KOZUMA, Y.
2007
5 6 p. 1274-1282
artikel
13 Corrigendum 2007
5 6 p. 1343
artikel
14 Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials DAVIDSON, B. L.
2007
5 6 p. 1191-1194
artikel
15 Effect of wine phenolics on cytokine-induced C-reactive protein expression KAUR, G.
2007
5 6 p. 1309-1317
artikel
16 Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer COHN, E. F.
2007
5 6 p. 1227-1236
artikel
17 Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet–leukocyte activation: role of P-selectin NEMMAR, A.
2007
5 6 p. 1217-1226
artikel
18 Evidence of a U-shaped association between factor XII activity and overall survival ENDLER, G.
2007
5 6 p. 1143-1148
artikel
19 Feasibility and accuracy of a rapid ‘point-of-care’ D-dimer test performed with a capillary blood sample VAN DER VELDE, E. F.
2007
5 6 p. 1327-1329
artikel
20 Fibrinolysis in a lipid environment: modulation through release of free fatty acids RÁBAI, G.
2007
5 6 p. 1265-1273
artikel
21 Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers SABBÀ, C.
2007
5 6 p. 1149-1157
artikel
22 High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses KEENAN, C. R.
2007
5 6 p. 1185-1190
artikel
23 Increased plasmin-α2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses BOUMA, B.
2007
5 6 p. 1139-1142
artikel
24 Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study ZAKAI, N. A.
2007
5 6 p. 1128-1135
artikel
25 Inflammatory/hemostatic biomarkers and cardiovascular risk: coming of age? LOWE, G. D. O.
2007
5 6 p. 1125-1127
artikel
26 Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions GUÉANT-RODRIGUEZ, R.-M.
2007
5 6 p. 1209-1216
artikel
27 Linkage analysis for three coagulation factors clustering on chromosome 13q34: factor VII, factor X and protein Z VOSSEN, C. Y.
2007
5 6 p. 1325-1326
artikel
28 Local tissue-type plasminogen activator release in patients with ischemic stroke JOOD, K.
2007
5 6 p. 1320-1322
artikel
29 Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin PIGNATELLI, P.
2007
5 6 p. 1170-1178
artikel
30 Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen γ′/γA mRNA ratio UITTE DE WILLIGE, S.
2007
5 6 p. 1243-1249
artikel
31 Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis VIGEN, C.
2007
5 6 p. 1201-1208
artikel
32 Role of elevated α2-macroglobulin revisited: results of a case-control study in children with symptomatic thromboembolism BEHEIRI, A.
2007
5 6 p. 1179-1184
artikel
33 Thalidomide causes platelet activation, which can be abrogated by aspirin DUNKLEY, S.
2007
5 6 p. 1323-1324
artikel
34 The bloody path of amyloids and prions HAMMARSTRÖM, P.
2007
5 6 p. 1136-1138
artikel
35 The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolysis rate: a rebuttal WILLEMSE, J. L.
2007
5 6 p. 1334-1336
artikel
36 The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolytic rate: reply to a rebuttal VALNICKOVA, Z.
2007
5 6 p. 1336-1337
artikel
37 The intrinsic pathway of coagulation: a target for treating thromboembolic disease? GAILANI, D.
2007
5 6 p. 1106-1112
artikel
38 The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease KIM, P. Y.
2007
5 6 p. 1250-1256
artikel
39 The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins α5β1 and αvβ3 AOKI, S.
2007
5 6 p. 1292-1301
artikel
40 The tissue factor–factor VIIa complex: procoagulant activity, regulation, and multitasking MONROE, D. M.
2007
5 6 p. 1097-1105
artikel
41 The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells DOU, L.
2007
5 6 p. 1302-1308
artikel
42 Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets LOPEZ, J. J.
2007
5 6 p. 1283-1291
artikel
43 Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin®): a prospective study of 50 patients BOREL-DERLON, A.
2007
5 6 p. 1115-1124
artikel
44 von Willebrand disease: treatment with or without factor VIII? KONKLE, B. A.
2007
5 6 p. 1113-1114
artikel
                             44 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland